These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9533779)

  • 21. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
    Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
    Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2003; (1):CD003280. PubMed ID: 12535467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic inflammatory demyelinating polyneuropathy.
    Rizzuto N; Simonati A
    Int J Tissue React; 1985; 7(6):521-6. PubMed ID: 4086221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V; Kalita J; Misra UK
    Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.
    Hahn AF; Bolton CF; Zochodne D; Feasby TE
    Brain; 1996 Aug; 119 ( Pt 4)():1067-77. PubMed ID: 8813271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed connective tissue disease associated with chronic inflammatory demyelinating polyneuropathy.
    Luostarinen L; Himanen SL; Pirttilä T; Molnar G
    Scand J Rheumatol; 1999; 28(5):328-30. PubMed ID: 10568432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy.
    Simmons Z; Albers JW; Bromberg MB; Feldman EL
    Neurology; 1993 Nov; 43(11):2202-9. PubMed ID: 8232929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis.
    Bamba S; Tsujikawa T; Inatomi O; Nakahara T; Koizumi Y; Saitoh Y; Sasaki M; Fujiyama Y; Andoh A
    J Gastroenterol Hepatol; 2010 Mar; 25(3):494-8. PubMed ID: 20370728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis.
    Vitale AT; Rodriguez A; Foster CS
    Ophthalmology; 1996 Mar; 103(3):365-73; discussion 373-4. PubMed ID: 8600411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of therapeutic apheresis in acute, relapsing, and chronic inflammatory demyelinating polyneuropathy.
    Tindall RS
    Prog Clin Biol Res; 1982; 106():205-17. PubMed ID: 6757941
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rapid improvement of nerve conduction in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Saito Y; Yokota T
    Rinsho Shinkeigaku; 1993 Oct; 33(10):1066-9. PubMed ID: 8293607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
    RMC Trial Group
    Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Steroid therapy and plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy: a long-term follow-up study].
    Hanaoka N; Hanyu N; Yanagisawa N
    Rinsho Shinkeigaku; 1998 Mar; 38(3):208-12. PubMed ID: 9711115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria.
    Barohn RJ; Kissel JT; Warmolts JR; Mendell JR
    Arch Neurol; 1989 Aug; 46(8):878-84. PubMed ID: 2757528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A.
    Mahattanakul W; Crawford TO; Griffin JW; Goldstein JM; Cornblath DR
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):185-7. PubMed ID: 8708650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The spectrum of acquired demyelinating polyradiculoneuropathy.
    Hughes RA
    Acta Neurol Belg; 1994; 94(2):128-32. PubMed ID: 8036880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensorimotor neuropathy resembling CIDP in patients receiving FK506.
    Wilson JR; Conwit RA; Eidelman BH; Starzl T; Abu-Elmagd K
    Muscle Nerve; 1994 May; 17(5):528-32. PubMed ID: 7512691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy.
    Simmons Z; Albers JW; Bromberg MB; Feldman EL
    Brain; 1995 Apr; 118 ( Pt 2)():359-68. PubMed ID: 7735878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.